Core Insights - CARBIOS has suspended its liquidity contract with Natixis ODDO BHF as of January 19, 2026, due to satisfactory liquidity of its shares [2][3]. - As of December 31, 2025, the liquidity account held 12,989 shares and €198,347.09 [2]. - The liquidity contract was established in accordance with the French Financial Market Authority's regulations [3]. Company Overview - CARBIOS is a biotechnology company focused on developing biological solutions for plastics and textiles, aiming to prevent pollution and promote a circular economy [4]. - The company has two main technologies: PET biorecycling and PLA biodegradation, which are being scaled to industrial levels [4]. - CARBIOS collaborates with major brands in various industries, including Nestlé Waters, PepsiCo, and L'Oréal, to enhance product recyclability [4]. Trading Activity - During the semester, there were 3,209 buy-side executions totaling 509,491 shares traded for €4,740,354.18, while sell-side executions totaled 3,538 for 512,000 shares at €4,738,838.30 [6]. - The liquidity account showed a consistent trading volume, indicating active market participation [6].

Core Viewpoint - CARBIOS is committed to advancing the construction of its Longlaville plant, with a revised timeline and significant pre-commercialization contracts in place to support its financing efforts [2][8]. Financing and Project Timeline - A small portion of the financing is still required, with the goal to secure it by the end of Q1 2026, allowing for the plant to be commissioned in the first half of 2028 [5][8]. - The project has secured public funding of €42.5 million and is expected to be financially independent from CARBIOS through non-recourse financing [4][8]. - CARBIOS anticipates having over €55 million in available cash by the end of 2025, providing visibility on its financing horizon for the next twelve months [8]. Commercialization and Market Engagement - In 2025, CARBIOS signed pre-commercialization contracts covering nearly 50% of the production capacity at the Longlaville site, with aims to increase this to 70% soon [3][8]. - The company is actively pursuing commercialization of its technology licenses, having established a strategic partnership with Wankai New Materials for deployment in Asia, and plans to expand into Europe and the Americas [6][12]. Technological and Environmental Commitment - CARBIOS focuses on developing biological solutions for plastic and textile lifecycle management, utilizing enzyme-based processes for PET biorecycling and PLA biodegradation [7]. - The company collaborates with major brands in the cosmetics, food, and apparel sectors to enhance product recyclability and support a circular economy [7].

Core Insights - Carbios and Wankai have established a joint venture to develop a PET biorecycling plant in China, marking a significant step in their strategic partnership aimed at addressing plastic pollution through innovative recycling technology [4][5][10] Company Developments - The joint venture will exclusively license Carbios' PET depolymerization technology to Wankai for three years, with the potential for extension based on additional capacity agreements [1] - The initial processing capacity of the plant is set at a minimum of 50,000 metric tons of prepared PET waste per year, with ambitions to expand further [2] - Construction of the biorecycling plant is expected to begin in the first quarter of 2026, with commissioning targeted for the first quarter of 2027 [10] Financial Aspects - Wankai has agreed to participate in a capital increase of 5 million euros (approximately $5.83 million) in Carbios by June 2024, with shares priced at 8.09 euros ($9.44) each [9] - Following the announcement of the strategic partnership, shares of Carbios increased by over 25% on the Euronext Growth Paris stock market, closing at 11.50 euros ($13.37) [4] Industry Context - China is the largest producer of PET globally, accounting for 38% of the world's recycled PET consumption in 2021, with significant potential for growth in rPET production [11][12] - The region produces 67 million tons of PET annually, representing 61% of global production, highlighting the strategic importance of establishing recycling facilities in Asia [12]

France-based CARBIOS and China’s Wankai New Materials, a listed subsidiary of Zhink Group, have agreed to form a joint venture (JV) partnership for the industrial rollout of CARBIOS’ polyethylene terephthalate (PET) biorecycling technology in Asia. The partnership will start with a new facility in China. Following the signing yesterday (2 December), the two companies have sealed a shareholders’ agreement to create a JV that will construct and operate what is described as the debut PET biorecycling plant ...

Core Points - CARBIOS and Wankai New Materials have established a strategic partnership for the large-scale deployment of CARBIOS's PET biorecycling technology in Asia, starting with a PET biorecycling plant in China [1][2][3] Company Overview - CARBIOS is a biotechnology company focused on developing biological solutions to reinvent the lifecycle of plastics and textiles, aiming to prevent plastic pollution and promote a circular economy [2][3] - The company has two main technologies: PET biorecycling and PLA biodegradation, with an operational industrial demonstration plant since 2021 [2] Partnership Details - The joint venture will construct a PET biorecycling plant in Haining, Zhejiang province, with a processing capacity of 50,000 tons of PET waste [3] - Wankai will hold a 70% stake in the joint venture, while CARBIOS will retain 30% [3] - The estimated construction cost of the plant is €115 million, financed by 30% equity and 70% debt, with all debt guaranteed by Wankai [3] Future Plans - Construction of the plant is expected to begin in Q1 2026, with commissioning targeted for Q1 2027 [3] - CARBIOS has committed to exclusively license its PET depolymerization technology in Asia to Wankai for three years, with potential extensions based on additional capacity agreements [3] Financial Commitment - Wankai will subscribe to a capital increase of €5 million in CARBIOS S.A. before June 2, 2026, at a share price of €8.0947, reflecting a 10% discount [3]

Core Points - CARBIOS and Wankai New Materials have established a strategic partnership for the large-scale deployment of CARBIOS's PET biorecycling technology in Asia, starting with a PET biorecycling plant in China [1][2][3] - The joint venture will have a processing capacity of 50,000 tons of PET waste, with Wankai holding a 70% stake and CARBIOS holding 30% [3] - The construction of the plant is estimated to cost €115 million, financed by 30% equity and 70% debt, with all debt guaranteed by Wankai [3] Company Overview - CARBIOS is a biotechnology company focused on developing biological solutions to reinvent the lifecycle of plastics and textiles, aiming to prevent plastic pollution and promote a circular economy [2] - The company has two main technologies: PET biorecycling and PLA biodegradation, with its industrial demonstration plant for biorecycling operational since 2021 [2] - CARBIOS collaborates with major brands in various industries to enhance the recyclability of their products and is part of the global community of B Corp™ certified companies [2] Partnership Details - The shareholders' agreement for the joint venture was signed on December 2, 2025, with construction expected to begin in Q1 2026 and commissioning targeted for Q1 2027 [3] - CARBIOS will exclusively license its PET depolymerization technology to Wankai for three years, with potential extensions based on additional capacity agreements [3] - Wankai has committed to a €5 million capital increase in CARBIOS S.A. before June 2, 2026, at a share price of €8.0947, reflecting a 10% discount [3]

Core Points - CARBIOS and Wankai New Materials have signed an agreement to collaborate on deploying CARBIOS' PET enzymatic recycling technology in Asia, marking a significant step in the development of a circular PET industry in the region [1][6][8] Group 1: Agreement Details - The agreement establishes a long-term commitment to build and operate several PET biorecycling plants in Asia, targeting a total capacity of one million tonnes per year [2][8] - The first joint venture will focus on constructing a PET biorecycling plant in China with an annual processing capacity of 50,000 tonnes of PET waste [3][8] - Wankai will be the main shareholder of the joint venture, which will be financed by Wankai, and is expected to start construction in the first quarter of 2026 [4][8] Group 2: Financial Aspects - Wankai will invest €5 million in CARBIOS S.A. to strengthen the strategic partnership [4] - The finalization of the partnership, including the shareholders' agreement and license agreement, is expected by the end of 2025 [5][8] Group 3: Strategic Importance - China, as the world's leading producer of PET, is a crucial market for CARBIOS, and this agreement is seen as a strategic advancement for both companies [6][8] - The collaboration aims to accelerate the transition to a more circular and low-carbon PET industry [7][8]

Core Points - CARBIOS and Wankai New Materials have signed a fundamental agreement to collaborate on deploying CARBIOS' enzymatic PET recycling technology in Asia [1][2] - The partnership aims to build and operate multiple biorecycling plants in Asia with a target capacity of 1 million tons per year [2][9] - The first step involves creating a joint venture to construct and operate a biorecycling plant in China with an annual capacity of 50,000 tons of PET waste [3][9] Company Overview - CARBIOS is a biotechnology company focused on developing biological solutions to reinvent the lifecycle of plastics and textiles, utilizing enzyme-based processes for plastic deconstruction [8] - The company has been operational since 2021 with its industrial demonstration plant for biorecycling and plans to commence construction of the world's first biorecycling plant by the end of 2025, pending additional funding [8] - CARBIOS is supported by prestigious brands in the cosmetic, food, and apparel industries to enhance the recyclability and circularity of their products [8][10] Investment and Financial Aspects - Wankai will be the majority shareholder of the joint venture and will guarantee the financing for the first biorecycling plant, with an investment of €5 million in CARBIOS' capital [4][5] - The partnership remains subject to the finalization of definitive agreements, including a shareholders' pact and a licensing contract, with the goal of signing by the end of the year [5][9] Strategic Importance - The agreement marks a strategic step for both CARBIOS and Wankai, aiming to accelerate the development of a circular PET industry in Asia, which is a key market for CARBIOS as the world's largest PET producer [6][7] - This collaboration is seen as a significant milestone in the international deployment of CARBIOS' technology and its licensing model [7]

Group 1 - CARBIOS has released its Interim report for the first half of 2025, which is available for shareholders and the financial community [1] - The company focuses on developing and industrializing biological technologies aimed at reinventing the lifecycle of plastics and textiles [2] - CARBIOS has two main technologies: PET biorecycling and PLA biodegradation, which are currently being scaled up to industrial and commercial levels [2] Group 2 - The industrial demonstration plant for biorecycling has been operational since 2021, with the construction of the world's first biorecycling plant expected to resume before the end of 2025, pending additional funding [2] - CARBIOS collaborates with major brands in the cosmetics, food, and apparel industries to enhance the recyclability and circularity of their products [2] - The company is part of the global community of B Corp™ certified companies, indicating a commitment to transforming business models for the common good [2]

Financial Results - The company reported a solid cash position of €72 million as of June 30, 2025, providing a cash horizon of more than 12 months, thanks to a cost-saving plan executed in the first half of 2025 [2][6] - Revenue for the first half of 2025 was €519,000, compared to €73,000 in the same period of 2024, indicating significant growth [12][27] - The current operating loss improved to €17.6 million from €20 million year-over-year, attributed to reduced operating expenses and increased revenues [14][15] Regulatory Environment Developments - A new decree in France provides financial incentives for incorporating recycled materials into products, offering a €1,000/ton bonus for using biorecycled plastics in sensitive-contact packaging [3][9] - This regulatory change is expected to accelerate customer adoption of CARBIOS' technology, allowing the company to supply high-quality recycled PET (r-PET) at a competitive price [3][9] Longlaville PET Biorecycling Plant Update - The construction of the Longlaville biorecycling plant is expected to resume before the end of 2025, contingent upon securing additional funding [6][9] - The plant is set to be commissioned in the second half of 2027, with significant progress made in securing public funding and interest from private investors [6][9][13] - Pre-sales of products from the future plant are progressing, supported by a favorable regulatory environment [7][9] Licensing and Technological Development - The company remains committed to the commercialization of licenses for its technology, supported by technological maturity and ongoing negotiations with various partners [10] - CARBIOS has secured a significant portion of its raw material supply and signed polymerization contracts, strengthening the project's industrial foundations [7][10] Cash Flow and Financial Position - The net cash consumption for the first half of 2025 was €18.1 million, a decrease from €102.1 million in 2024, reflecting improved cash management [19][30] - Cash and cash equivalents at the end of the period stood at €71.7 million, down from €89.8 million at the beginning of the period [19][30]